Sleep & Recovery · Compounded
One prescribed peptide, one clinical review, ongoing care.
Compounded sermorelin, prescribed by a licensed U.S. provider after a clinical review and prepared for you by a licensed U.S. compounding pharmacy, with follow-up from your care team.
One quick question
$160/mo$479 for 90 daysAs low as $150/mo · $899 for 180 daysShipping included. Prepaid multi-month pricing is locked at purchase.
Compounded medications are prepared by licensed U.S. compounding pharmacies for an individual patient under a prescription. They are not approved by the FDA and have not been evaluated by the FDA for safety, effectiveness, or quality.
Intake and health information are handled by the licensed telehealth platform; this website never collects health information.
How it works
Four steps, every program.
The clinical review is never skipped, whatever you come here for.
- Intake.A private form inside a secure, HIPAA-compliant platform.
- Licensed-provider review.A licensed U.S. provider evaluates your intake and decides on treatment, which is never guaranteed.
- Shipment.The medication ordered is shipped discreetly to your home from a licensed 503A compounding pharmacy and typically arrives within 1–3 business days.
- Ongoing care.If prescribed, your care team follows up and adjusts the plan as needed.
What is in this program
One peptide therapy program with a single peptide.
Sermorelin is a synthetic fragment of growth-hormone-releasing hormone. Its regulatory history is unusual and worth stating plainly rather than glossing: a sermorelin product was FDA-approved in 1997 under the name GEREF, and the manufacturer voluntarily withdrew it from the U.S. market in 2008. FDA later determined that it was not withdrawn for reasons of safety or effectiveness.
That means two things at once. There is no FDA-approved sermorelin product marketed in the United States today, and the compounded preparation offered here is not an FDA-approved medicine. It is prescription-only and prepared for one named patient by a licensed U.S. compounding pharmacy. Saying sermorelin was "never approved" would be wrong; saying this program is approved would also be wrong.
Because there is no approved labeling in force for us to quote, this page does not state what sermorelin will do for you. That belongs to the licensed provider who has read your history.
Evidence and sources
What the sources say.
Every clinical statement on this page carries its source and the date it was last reviewed.
- A 503A compounding pharmacy prepares a medication for an individual patient under a prescription.
Safety and candor
Not for everyone — and that is the point of the review.
Compounded medications are prepared by licensed U.S. compounding pharmacies for an individual patient under a prescription. They are not approved by the FDA and have not been evaluated by the FDA for safety, effectiveness, or quality. Compounded medications have not been evaluated by the FDA for safety or effectiveness.
Not for people with
- Pregnancy, planning pregnancy, or breastfeeding
- Active cancer or a history of cancer (discuss with your provider)
- Diabetes or impaired glucose tolerance (discuss with your provider)
- Known hypersensitivity to the formulation
Treatment, prescriptions, and eligibility are determined by a licensed provider following an evaluation, and are never guaranteed.
FAQ
Questions
Is this FDA-approved?
The compounded preparation you would receive is not. A sermorelin product was approved in 1997 as GEREF and voluntarily withdrawn from the U.S. market in 2008 — FDA determined it was not withdrawn for safety or effectiveness reasons. No FDA-approved sermorelin product is marketed today.
Who decides whether I can start?
A licensed U.S. provider, after reviewing your intake and medical history. Treatment is never guaranteed, and it is not decided by Risen MD. If this program is not appropriate for you, your provider will tell you.